SKB118 Injection in Advanced Solid Tumors

Summary

This is a phase 1/2 clinical study to evaluate the safety and efficacy of SKB118 in participants with advanced solid tumors. The study includes a dose escalation stage, a dose expansion stage, and a indication expansion stage.

Timeline

Start

2026-06

Primary completion

2029-12

Completion

2030-12

Drugs

Indications